Zero‑Shot Design of Drug‑Binding Proteins Demonstrates High Accuracy and Affinity

Date:

By pairing two neural networks in an iterative optimization algorithm, researchers have shown that small‑molecule binding proteins can be designed from scratch with high accuracy, strong affinity and impressive success rates, suggesting new possibilities for drug delivery and sequestration.

A study published online June 24, 2026 in Nature describes a “zero‑shot” approach that combines a protein‑structure prediction network with a ligand‑binding predictor in a loop of selection and expansion. The method generates candidate proteins, evaluates their predicted binding to target small molecules, and iteratively refines the designs without relying on existing protein templates.

In benchmark tests, the newly designed proteins bound a range of drug‑like compounds with nanomolar affinities, rivaling or exceeding those of naturally occurring binders. The success rate—measured as the proportion of designs that achieved measurable binding—was reported to be markedly higher than previous computational protein‑design pipelines.

The authors highlight several potential applications, including creating bespoke carriers for therapeutic agents, developing sequestration tools to neutralize toxins, and accelerating the discovery of protein‑based diagnostics. Because the workflow does not require prior structural data for a target, it could be applied to emerging drugs and small molecules where conventional design methods fall short.

Analysis: The study represents a significant advance in computational protein engineering by integrating deep‑learning models for structure and function in a closed‑loop system. If the reported affinities and success rates hold up in broader experimental validation, the technique could shorten development timelines for protein therapeutics and enable rapid response to novel drug targets. However, real‑world deployment will require extensive testing for stability, immunogenicity and manufacturability—factors not addressed in the initial publication.

Sources
– Nature, “Zero‑shot design of drug‑binding proteins via neural iterative selection‑expansion,” published online 24 June 2026, https://www.nature.com/articles/s41586-026-10670-w


Source: Nature – Original article

Corrections

If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.

Story synopsis gathered from: Nature — source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

UK Competition Regulator Proposes Opening Apple iPhone Contactless Technology to Local Fintechs

The UK Competition and Markets Authority announced proposals on October 20, 2026, aimed at opening access to Near Field Communication technology on Apple iPhones, seeking to allow financial technology companies and other businesses to offer competing contactless services. According to…

BJP Retains Control of Gandhinagar Municipal Corporation With 38 Seats

The Bharatiya Janata Party secured 38 out of 44 seats in the Gandhinagar Municipal Corporation elections in Gujarat, retaining its administrative hold over the state capital's civic body. According to election data, voter turnout reached 59.25% among the municipal corporation's…

600,000 UK Families Boost Savings with Tax‑Free Childcare Scheme

More than 600,000 UK families used Tax-Free Childcare in June 2026, receiving GBP 55.7 million in government top-ups, according to official figures.

Justice Department Charges 16 Individuals in Federal Election Crime Sweep

The U.S. Department of Justice announced criminal charges against 16 individuals across the country involving allegations of illegal voting, fraudulent voter registration, and related election offenses, according to a press release issued on Oct. 12, 2026. The nationwide charges encompass…